Mucha-Malecka A - Search Results

1

Oxidative damage DNA: 8-oxoGua and 8-oxodG as molecular markers of cancer.

Roszkowski K, Jozwicki W, Blaszczyk P, Mucha-Malecka A, Siomek A. Roszkowski K, et al. Med Sci Monit. 2011 Jun;17(6):CR329-33. doi: 10.12659/msm.881805. Med Sci Monit. 2011. PMID: 21629187 Free PMC article.

2

[Predictive and prognostic value of p53, Ki-67 and EGFR in patients with advanced oral cavity and oropharyngeal cancer treated with induction chemotherapy].

Małecki K, Gliński B, Mucha-Małecka A, Roszkowski K, Hetnał M. Małecki K, et al. Przegl Lek. 2012;69(1):5-8. Przegl Lek. 2012. PMID: 22764511 Polish.

3

Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment.

Małecki K, Gliński B, Mucha-Małecka A, Ryś J, Kruczak A, Roszkowski K, Urbańska-Gąsiorowska M, Hetnał M. Małecki K, et al. Rep Pract Oncol Radiother. 2010 Aug 3;15(4):87-92. doi: 10.1016/j.rpor.2010.06.001. eCollection 2010. Rep Pract Oncol Radiother. 2010. PMID: 24376930 Free PMC article.

4

Potential survival markers in cancer patients undergoing chemotherapy.

Roszkowski K, Filipiak J, Wisniewska M, Mucha-Malecka A, Basta P. Roszkowski K, et al. Clin Exp Med. 2015 Aug;15(3):381-7. doi: 10.1007/s10238-014-0313-6. Epub 2014 Sep 28. Clin Exp Med. 2015. PMID: 25261922

5

Lack of CD44 overexpression and application of concurrent chemoradiotherapy with cisplatin independently indicate excellent prognosis in patients with HPV-positive oropharyngeal cancer.

Biesaga B, Kołodziej-Rzepa M, Janecka-Widła A, Słonina D, Halaszka K, Przewoźnik M, Mucha-Małecka A. Biesaga B, et al. Tumour Biol. 2021;43(1):99-113. doi: 10.3233/TUB-200049. Tumour Biol. 2021. PMID: 34024796 Free article.

6

Active HPV infection and its influence on survival in head and neck squamous-cell cancer.

Janecka-Widła A, Mucha-Małecka A, Majchrzyk K, Halaszka K, Przewoźnik M, Słonina D, Biesaga B. Janecka-Widła A, et al. J Cancer Res Clin Oncol. 2020 Jul;146(7):1677-1692. doi: 10.1007/s00432-020-03218-6. Epub 2020 May 5. J Cancer Res Clin Oncol. 2020. PMID: 32372145 Free PMC article.

7

[Cerebellar metastasis from ovarian carcinoma. A case report].

Urbański J, Mucha-Małecka A, Gliński B. Urbański J, et al. Ginekol Pol. 2005 Jun;76(6):481-3. Ginekol Pol. 2005. PMID: 16149267 Polish.

8

Hematogenous metastases in patients with Stage I or II endometrial carcinoma.

Blecharz P, Urbański K, Mucha-Małecka A, Małecki K, Reinfuss M, Jakubowicz J, Skotnicki P. Blecharz P, et al. Strahlenther Onkol. 2011 Dec;187(12):806-11. doi: 10.1007/s00066-011-2250-6. Epub 2011 Nov 17. Strahlenther Onkol. 2011. PMID: 22105770

9

Lymphangiogenesis assessed using three methods is related to tumour grade, breast cancer subtype and expression of basal marker.

Niemiec J, Adamczyk A, Ambicka A, Mucha-Małecka A, Wysocki W, Mituś J, Ryś J. Niemiec J, et al. Pol J Pathol. 2012 Nov;63(3):165-71. doi: 10.5114/pjp.2012.31500. Pol J Pathol. 2012. PMID: 23161232 Free article.

10

Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts.

Niemiec JA, Adamczyk A, Ambicka A, Mucha-Małecka A, M Wysocki W, Ryś J. Niemiec JA, et al. Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):10-6. doi: 10.1097/PAI.0b013e318286030d. Appl Immunohistochem Mol Morphol. 2014. PMID: 23455186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters